Features of severe asthma response to anti-IL5/IL5r therapies: identikit of clinical remission.
Carpagnano GE, Portacci A, Nolasco S, Detoraki A, Vatrella A, Calabrese C, Pelaia C, Montagnolo F, Scioscia G, Valenti G, D'Amato M, Caiaffa MF, Triggiani M, Scichilone N, Crimi C.
Carpagnano GE, et al.
Front Immunol. 2024 Jan 23;15:1343362. doi: 10.3389/fimmu.2024.1343362. eCollection 2024.
Front Immunol. 2024.
PMID: 38327518
Free PMC article.